EP Patent

EP0526862B1 — Solid pharmaceutical compositions for oral administration with prolonged gastric residence

Assigned to Vectorpharma International SpA · Expires 1996-02-14 · 30y expired

What this patent protects

Solid pharmaceutical compositions for oral administration, with prolonged residence in the stomach, consisting of one or more high density inorganic substances, one or more bioadhesive substances, an active ingredient - either as it is or mixed in a carrier system - as well as ex…

USPTO Abstract

Solid pharmaceutical compositions for oral administration, with prolonged residence in the stomach, consisting of one or more high density inorganic substances, one or more bioadhesive substances, an active ingredient - either as it is or mixed in a carrier system - as well as excipients, binders, lubricants and other materials commonly used in pharmaceutical formulations.

Drugs covered by this patent

Patent Metadata

Patent number
EP0526862B1
Jurisdiction
EP
Classification
Expires
1996-02-14
Drug substance claim
No
Drug product claim
No
Assignee
Vectorpharma International SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.